Skip to content
OpenCapital
Get started

Journey Medical Corporation DERM Enterprise value

Enterprise value at other companies

Bausch Health Companies logo
Bausch Health CompaniesBHC
$21.45B-5.6%
Cumberland Pharmaceuticals logo
Cumberland PharmaceuticalsCPIX
$42.43M-13.7%
PTH
Pelthos Therapeutics Inc.PTHS
$68.17M—
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
$3B+57.0%
HRO
HarrowHROW
$1.53B+13.8%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$2.27B-4.1%

Other financials

Income statement

See full
Revenue$16.0M+21.5%
Gross profit$9.7M+16.7%
Operating income-$1.5M+55.1%
Net income-$2.2M+45.2%
EPS (diluted)-$0.08+55.6%

Balance sheet

See full
Cash & equivalents$27.2M+29.2%
Total debt$25.5M+1.2%
Total equity$30.8M+43.1%
Total assets$91.5M+7.7%

Cash flow

See full
Operating cash flow$2.9M+203%
CapEx$3.8M—
Free cash flow-$6.0M—

Valuation

See full
Market cap$194.94M+20.9%
P/S3×+0.2×

Profitability

See full
Gross margin65.4%-1.0pp
Operating margin-9.8%—
Net margin-14.8%—
FCF margin-43%—

Returns & leverage

See full
Return on equity-36.6%—
Debt / equity0.8×-0.3×
Current ratio1.7×+0.4×

Where this comes from

Calculated from Journey Medical Corporation’s reported figures.

$128.2Mmarket cap+$25.5Mtotal debt−$27.2Mcash and equivalents=$126.43M

The official record: Journey Medical Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Journey Medical Corporation's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Journey Medical Corporation's enterprise value?
Journey Medical Corporation (DERM) reported enterprise value of $126.43M in Q1 2026.
How has Journey Medical Corporation's enterprise value changed year-over-year?
Journey Medical Corporation's enterprise value decreased by 10.0% year-over-year, from $140.41M to $126.43M.
What is the long-term trend for Journey Medical Corporation's enterprise value?
Over 4 years (2021 to 2025), Journey Medical Corporation's enterprise value has grown at a 47.7% compound annual growth rate (CAGR), from $44.19M to $210.52M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.